MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Bayer AG Company Profile (OTCMKTS:BAYRY)

Consensus Ratings for Bayer AG (OTCMKTS:BAYRY) (?)
Ratings Breakdown: 6 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.54)
Consensus Price Target: $130.00

Analysts' Ratings History for Bayer AG (OTCMKTS:BAYRY)
Show:
DateFirmActionRatingPrice TargetActions
5/26/2016Sanford C. BernsteinReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/25/2016Commerzbank AGUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/25/2016Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/25/2016DZ Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Citigroup Inc.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Goldman SachsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Credit SuisseDowngradeOutperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Nord/LBReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016BarclaysUpgradeUnderweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2015HSBCUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2015Jefferies GroupBoost Price TargetHold$130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015Societe GeneraleReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Equinet Institutional ServicesUpgradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Morgan StanleyDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2014Erste GroupUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/25/2014BNP ParibasInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2014Kepler Capital MarketsUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Bayer AG (OTCMKTS:BAYRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/29/2015Q3$1.65$1.88ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015$2.35$2.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015$1.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014$2.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/20/2014$2.47$2.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Bayer AG (OTCMKTS:BAYRY)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Bayer AG (OTCMKTS:BAYRY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Bayer AG (OTCMKTS:BAYRY)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Bayer AG (OTCMKTS:BAYRY)
DateHeadline
06/28/16 02:56 PMMonsanto Earnings: What to Watch
06/28/16 12:37 PMWhat to Look for When Monsanto (MON) Posts Q3 Earnings -
06/28/16 08:51 AMNot intended for U.S. and UK Media: Phase III data at ESMO 18th World Congress on Gastrointestinal Cancer (WCGC): -- Bayer’s Regorafenib Significantly Improves Overall Survival in Patients with Unresectable Liver Cancer -- Initial results f - [at noodls] - Berlin, June 28, 2016 - Bayer today announced results from the Phase III RESORCE trial investigating its oncology compound regorafenib in patients with unresectable hepatocellular carcinoma (HCC) who progressed ...
06/28/16 08:03 AM9:03 am Bayer AG announces that results from the Phase III RESORCE trial show that Stivarga tablets achieved a median overall survival improvement in patients with unresectable hepatocellular carcinoma who progressed after treatment with Ne -
06/27/16 02:23 PMDoes Brexit Affect The Bayer-Monsanto Deal? - Seeking Alpha
06/27/16 07:27 AMGrim Year for U.K. M&A Made More Uncertain by Britain’s Decision to Leave EU
06/27/16 07:27 AMNext Weeks Broker Price Targets For Bayer AG (BAYRY) - Fiscal Standard
06/25/16 02:44 PMHow Analysts Rated Bayer AG (ADR) (OTCMKTS:BAYRY) Last Week? - Press Telegraph
06/24/16 10:30 AMIt's Time To Sell One Of My Favorite Companies -
06/23/16 02:40 PMBayer: We Don't Need Investors' OK to Buy Monsanto -
06/22/16 02:45 PMBayer AG (BAYRY) Updated Price Targets - FTSE News
06/22/16 02:20 PMBayer to shareholders: We don’t need your approval for Monsanto deal -
06/22/16 07:32 AMDupont, Bayer join ag-tech investment boom
06/20/16 01:01 PMBayer crop unit apologizes to farmers after Twitter gaffe -
06/20/16 10:09 AMBayer at the International Weed Science Congress, June 19-25, 2016 in Prague: -- Scientists agree: Farmers worldwide urgently need new solutions in weed control -- Weed resistance growing in many countries and crops / Bayer speeding up its - [at noodls] - Monheim, June 20, 2016- At the International Weed Science Congress in Prague, scientists from 57 countries have come together to discuss the way forward in weed control and possible solutions against the ...
06/20/16 09:08 AMOphthotech completes enrollment in late-stage study of lead product candidate, in combination with Eylea or Avastin, in wet AMD
06/19/16 07:25 AMThis Weeks Broker Views For Bayer AG (BAYRY) - Fiscal Standard
06/19/16 01:00 AMAngst grows over agrochemical mega-mergers -
06/17/16 10:40 AMParatek Reports Positive Phase III Data on Antibiotic Drug
06/17/16 10:33 AMExclusive - Bayer explores sale of radiology business : sources -
06/17/16 10:30 AMExclusive: Bayer explores sale of radiology business - sources -
06/15/16 02:49 PMArgus Is Bullish On Monsanto Regardless Of Merger Talk Outcome
06/15/16 07:32 AMUBS Optimistic On Monsanto Deal, Raises Price Target To Match Bayer Bid
06/14/16 02:41 PMMaterial Girls: Materials ETFs Look For More Upside
06/14/16 07:09 AMInnovative packaging technology from Bayer launched in Europe: -- Bayer CapSeal protects against counterfeit crop protection products -- Combination of cap seal with visual security features / QR code and mobile app offer enhanced protectio - [at noodls] - Monheim, June 14, 2016- Bayer has developed a new cap seal to protect users against counterfeit crop protection products. The Bayer CapSeal, based on the Trustseal technology of the Leonhard Kurz Stiftung, ...
06/13/16 11:58 AMEuropean Markets Fall On Heightened 'Brexit' Worries -
06/13/16 10:45 AMBayer On Monsanto Bid: Push Toward Digital Farming
06/10/16 07:28 PM[$$] Monsanto Turns Back Bayer Again -
06/10/16 02:47 PMMonsanto Acquisition Play
06/10/16 02:25 PMMonsanto says no to Bayer's request for more info: Report -
06/10/16 01:46 PM[$$] Monsanto Rebuffs New Approach From Bayer -
06/10/16 01:31 PMMonsanto (MON) Stock Drops After Rejecting Second Bayer Offer -
06/10/16 01:26 PMMonsanto Said to Rebuff New Bayer Offer at Same Price: DJ -
06/07/16 05:12 AMEuropean Stocks Rally After Yellen Comments, Growth Uplift -
06/06/16 05:00 PMDeutsche Bank Is Only Thing Missing From Germany’s Biggest Deal -
06/06/16 10:52 AM[$$] Brussels threatens to eradicate weed killer sold by Monsanto - [at Financial Times] - The EU risks a legal showdown with farming unions and agrichemical companies after leading member states on Monday refused to extend a licence for glyphosate, the world's most common herbicide and a top ...
06/03/16 08:55 AMMonsanto Bid Shows Courage Bayer Chairman Sees as Key to Success -
06/02/16 02:37 PMBayer secures loan facility to fund Monsanto bid - report -
06/02/16 01:57 PMBayer AG secures 60 bln euros loan facility to fund Monsanto offer - report - June 2 (Reuters) - German drugs and crop chemicals group Bayer AG has secured a loan facility of 60 billion euros ($66.94 billion) to fund its $62 billion offer for U.S. seeds company Monsanto Co,...
06/02/16 11:09 AMEuropean Markets End Day Mixed After ECB Leaves Rates Unchanged -
06/02/16 09:04 AMWhat’s the Potential Upside in the Bayer-Monsanto Deal? -
06/01/16 02:47 PMBroker Watchlist: Bayer AG (BAYRY) - Share Trading News - Broker Watchlist: Bayer AG (BAYRY)Share Trading NewsThe share price of Bayer AG (BAYRY) was up +0.19% during the last trading session, with a day high of 96.26. 445964 shares were traded on Bayer AG's last session. The stock's 50 day moving average is 111.87 and its 200 day moving average is 115.60.
06/01/16 02:13 AMBayer collaborates with U.S. National Surgical Adjuvant Breast and Bowel Project (NSABP) to Investigate Stivarga® (Regorafenib) as Additional Adjuvant Therapy in Colon Cancer - [at noodls] - Study will include patients with Stage IIIB and IIIC colon cancer who have undergone complete surgical resection of primary tumor and received standard adjuvant chemotherapy / Indication-seeking trial ...
06/01/16 02:12 AMMonsanto deal will take time, says Bayer CEO -
05/31/16 02:49 PMBayer AG (ADR) (OTCMKTS:BAYRY)'s Initial Offer to Acquire Monsanto Co. Rejected - Journal Transcript - Journal TranscriptBayer AG (ADR) (OTCMKTS:BAYRY)'s Initial Offer to Acquire Monsanto Co. RejectedJournal TranscriptBayer AG (ADR) (OTCMKTS:BAYRY)'s $62 billion, all cash, bid to acquire Monsanto Co. has been rejected, by the Monsanto's management, but further talks are underway. The details of the deal have only recently surfaced, even though an acquisition had ...
05/31/16 09:10 AMStock Market News for May 31, 2016 -
05/31/16 09:02 AMImproving agriculture with crop-specific satellite images -- Bayer and Planetary Resources intend to collaborate to improve agriculture with space data - [at noodls] - Monheim, May 31, 2016 - Bayer and the aerospace technology company Planetary Resources, based in Redmond, Washington, USA, have signed a memorandum of understanding about the development of applications ...
05/31/16 08:38 AMMonsanto (MON) Stock Soaring on Possibility of Improved Bayer Bid -
05/31/16 08:02 AMBayer and Cefetra join forces to promote sustainable agricultural practices in Latin America - [at noodls] - Monheim/Rotterdam, May, 31, 2016- Bayer and the agricultural supply chain manager Cefetra, a BayWa company, have started a Food Chain Partnership designed to drive sustainable cultivation of agricultural ...
05/31/16 07:51 AMBayer’s Offer to Acquire Monsanto: What You Need to Know -
About Bayer AG

Bayer AG logoBayer AG is a Germany-based chemical and pharmaceutical company. The Company's business operations are organized into three segments: Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. Bayer HealthCare researches, develops, manufactures and markets products to improve the health of people and animals. Bayer CropScience is engaged in the crop protection and non-agricultural pest control. Bayer MaterialScience supplies polymers, and develops solution for a range of applications. The Company's subsidiaries include Adverio Pharma GmbH, AgrEvo Verwaltungsgesellschaft mbH, Alcafleu Management GmbH & Co KG, Bayer Beteiligungsverwaltung Goslar GmbH, Bayer MaterialScience Customer Services GmbH, Schering-Kahlbaum Gesellschaft mit beschraenkter Haftung, proPlant Gesellschaft fuer Agrar- und Umweltinformatik mbH and KOSINUS Grundstuecks-Verwaltungsgesellschaft mbH & Co Gamma OHG.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: BAYRY
  • CUSIP:
Key Metrics:
  • Previous Close: $99.62
  • 50 Day Moving Average: $101.88
  • 200 Day Moving Average: $111.40
  • P/E Ratio: 17.08
  • P/E Growth: 1.52
  • Market Cap: $82.38B
  • Current Quarter EPS Consensus Estimate: $8.35 EPS
Additional Links:
Bayer AG (OTCMKTS:BAYRY) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha